XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 115,642 $ 30,511
Prepaid expenses 116,536
Total Current Assets 232,178 30,511
Deferred offering costs 168,973
Investments held in Trust Account – US Treasury Securities Money Market Fund 139,408,006
TOTAL ASSETS 139,640,184 199,484
Current liabilities    
Accounts payable and accrued expenses 43,569
Accrued offering costs 25,760
Advances from related party 30,000
Promissory note — related party 125,000
Total Current Liabilities 43,569 180,760
Warrant liability 4,856,400
Deferred underwriting fee payable 5,190,000
Total Liabilities 10,089,969 180,760
Commitments and Contingencies
Ordinary shares subject to possible redemption 13,800,000 as of September 30, 2021 and no shares as of December 31, 2020 at redemption value of $10.10 139,380,000
Shareholders’ (Deficit) Equity    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 3,450,000 non-redeemable shares issued and outstanding at September 30, 2021 and December 31, 2020 (1) [1] 345 345
Additional paid-in capital 24,655
Accumulated deficit (9,830,130) (6,276)
Total Shareholders’ (Deficit) Equity (9,829,785) 18,724
TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY $ 139,640,184 $ 199,484
[1] At December 31, 2020, includes an aggregate of up to 450,000 ordinary shares that are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised (see Note 6). On January 6, 2021, the Company effected a share capitalization of 0.2 shares for each share outstanding, resulting in 3,450,000 ordinary shares issued and outstanding (see Note 6). All share and per share amounts have been retroactively restated to reflect the share capitalization.  As a result of the underwriters’ full exercise of their overallotment option on January 11, 2021, no shares were forfeited.